Medicine
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
By Eli Lilly ・ Jan 07, 2026
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addre...
READ MORE →